前のページに戻る この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写(冊子体のコピー)をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID:202202247118346854   整理番号:22A0215154

腫瘍DNA-メチローム由来エピジェネティックフィンガープリントは術後放射線化学療法後の局所再発のリスクでHPV陰性頭頸部患者を同定する【JST・京大機械翻訳】

Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy
著者 (113件):
Tawk Bouchra
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
Tawk Bouchra
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
Tawk Bouchra
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
Tawk Bouchra
(Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany)
Tawk Bouchra
(Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University, Heidelberg, Germany)
Wirkner Ute
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
Wirkner Ute
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
Wirkner Ute
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
Wirkner Ute
(Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany)
Wirkner Ute
(Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University, Heidelberg, Germany)
Schwager Christian
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
Schwager Christian
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
Schwager Christian
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
Schwager Christian
(Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany)
Schwager Christian
(Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University, Heidelberg, Germany)
Rein Katrin
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
Rein Katrin
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
Rein Katrin
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
Rein Katrin
(Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany)
Rein Katrin
(Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University, Heidelberg, Germany)
Zaoui Karim
(Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, Heidelberg, Germany)
Federspil Philippe A.
(Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, Heidelberg, Germany)
Adeberg Sebastian
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
Adeberg Sebastian
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
Adeberg Sebastian
(Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany)
Adeberg Sebastian
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany)
Linge Annett
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
Linge Annett
(German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany)
Linge Annett
(Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
Linge Annett
(OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
Linge Annett
(National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany)
Linge Annett
(Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
Linge Annett
(Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany)
Ganswindt Ute
(German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany)
Ganswindt Ute
(Department of Radiation Oncology, Medical University of Innsbruck, Innsbruck, Austria)
Hess Julia
(Department of Radiation Oncology, University Hospital Ludwig-Maximilians-University of Munich, Munich, Germany)
Hess Julia
(Research Unit Radiation Cytogenetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
Hess Julia
(Clinical Cooperation Group “Personalized Radiotherapy in Head and Neck Cancer”, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
Unger Kristian
(Department of Radiation Oncology, University Hospital Ludwig-Maximilians-University of Munich, Munich, Germany)
Unger Kristian
(Research Unit Radiation Cytogenetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
Unger Kristian
(Clinical Cooperation Group “Personalized Radiotherapy in Head and Neck Cancer”, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
Tinhofer Ingeborg
(German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany)
Tinhofer Ingeborg
(Department of Radiooncology and Radiotherapy, Charite University Hospital, Berlin, Germany)
Budach Volker
(German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany)
Budach Volker
(Department of Radiooncology and Radiotherapy, Charite University Hospital, Berlin, Germany)
Lohaus Fabian
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
Lohaus Fabian
(German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany)
Lohaus Fabian
(Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
Lohaus Fabian
(OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
Lohaus Fabian
(National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany)
Lohaus Fabian
(Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
Lohaus Fabian
(Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany)
Krause Mechthild
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
Krause Mechthild
(German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany)
Krause Mechthild
(Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
Krause Mechthild
(OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
Krause Mechthild
(National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany)
Krause Mechthild
(Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
Krause Mechthild
(Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany)
Guberina Maja
(German Cancer Consortium (DKTK), Partner Site Essen, Essen, Germany)
Guberina Maja
(Department of Radiotherapy, Medical Faculty, University of Duisburg-Essen, Essen, Germany)
Stuschke Martin
(Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
Stuschke Martin
(Department of Radiotherapy, Medical Faculty, University of Duisburg-Essen, Essen, Germany)
Balermpas Panagiotis
(German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany)
Balermpas Panagiotis
(Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland)
Rodel Claus
(German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany)
Rodel Claus
(Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany)
Grosu Anca L.
(German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany)
Grosu Anca L.
(Department of Radiation Oncology, Clinical Study Section, University of Freiburg, Freiburg, Germany)
Grosu Anca L.
(Department of Radiation Oncology, University of Freiburg, Freiburg, Germany)
Schaefer Henning
(German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany)
Schaefer Henning
(Department of Radiation Oncology, Clinical Study Section, University of Freiburg, Freiburg, Germany)
Zips Daniel
(German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany)
Zips Daniel
(Department of Radiation Oncology, Faculty of Medicine and University Hospital Tuebingen, Eberhard Karls Universitaet Tuebingen, Tuebingen, Germany)
Combs Stephanie E.
(German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany)
Combs Stephanie E.
(Department of Radiation Oncology, Technische Universitaet Muenchen, Munich, Germany)
Pigorsch Steffi
(German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany)
Pigorsch Steffi
(Department of Radiation Oncology, Technische Universitaet Muenchen, Munich, Germany)
Zitzelsberger Horst
(Department of Radiation Oncology, University Hospital Ludwig-Maximilians-University of Munich, Munich, Germany)
Zitzelsberger Horst
(Research Unit Radiation Cytogenetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
Zitzelsberger Horst
(Clinical Cooperation Group “Personalized Radiotherapy in Head and Neck Cancer”, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
Baumeister Philipp
(Research Unit Radiation Cytogenetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
Baumeister Philipp
(Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany)
Kirchner Thomas
(German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany)
Kirchner Thomas
(Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany)
Bewerunge-Hudler Melanie
(Genomics and Proteomics Core Facility, German Cancer Research Center, Heidelberg, Germany)
Weichert Wilko
(German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany)
Weichert Wilko
(Institute of Pathology, Technische Universitaet Muenchen, Munich, Germany)
Hess Jochen
(Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, Heidelberg, Germany)
Hess Jochen
(Department of Molecular Mechanisms of Head and Neck Tumors, German Cancer Research Center, Heidelberg, Germany)
Herpel Esther
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
Herpel Esther
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
Herpel Esther
(Tissue Bank, National Center for Tumor Diseases (NCT), Heidelberg, Germany)
Herpel Esther
(Department of Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany)
Belka Claus
(German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany)
Belka Claus
(Department of Radiation Oncology, University Hospital Ludwig-Maximilians-University of Munich, Munich, Germany)
Belka Claus
(Research Unit Radiation Cytogenetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
Baumann Michael
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
Baumann Michael
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
Baumann Michael
(German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany)
Baumann Michael
(Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
Baumann Michael
(OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
Debus Juergen
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
Debus Juergen
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
Debus Juergen
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
Debus Juergen
(Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany)
Debus Juergen
(Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University, Heidelberg, Germany)
Abdollahi Amir
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
Abdollahi Amir
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
Abdollahi Amir
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
Abdollahi Amir
(Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany)
Abdollahi Amir
(Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University, Heidelberg, Germany)
For the DKTK-ROG

資料名:
International Journal of Cancer  (International Journal of Cancer)

巻: 150  号:ページ: 603-616  発行年: 2022年 
JST資料番号: A0267B  ISSN: 0020-7136  資料種別: 逐次刊行物 (A)
記事区分: 原著論文  発行国: アメリカ合衆国 (USA)  言語: 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写(コピー)して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写(コピー)は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。